Antifibrotic effect after low-dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open-label non-randomized, uncontrolled clinical trial. (Q45761415)
Jump to navigation
Jump to search
scientific article published on 20 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antifibrotic effect after low-dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open-label non-randomized, uncontrolled clinical trial. |
scientific article published on 20 December 2011 |
Statements
Antifibrotic effect after low-dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open-label non-randomized, uncontrolled clinical trial (English)
T R Elmholdt
M Ramsing
20 December 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference